Donnem T - Search Results

1

The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer.

Bremnes RM, Al-Shibli K, Donnem T, Sirera R, Al-Saad S, Andersen S, Stenvold H, Camps C, Busund LT. Bremnes RM, et al. Among authors: donnem t. J Thorac Oncol. 2011 Apr;6(4):824-33. doi: 10.1097/JTO.0b013e3182037b76. J Thorac Oncol. 2011. PMID: 21173711 Free article. Review.

2

High-grade non-Hodgkin's lymphoma treated in northern Norway--treatment, outcome, and prognostic factors.

Bremnes RM, Bremnes Y, Dønnem T. Bremnes RM, et al. Among authors: donnem t. Acta Oncol. 1999;38(1):117-24. doi: 10.1080/028418699431906. Acta Oncol. 1999. PMID: 10090699

3

Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.

Donnem T, Al-Saad S, Al-Shibli K, Delghandi MP, Persson M, Nilsen MN, Busund LT, Bremnes RM. Donnem T, et al. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6649-57. doi: 10.1158/1078-0432.CCR-07-0414. Clin Cancer Res. 2007. PMID: 18006765

4

VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells.

Donnem T, Al-Shibli K, Al-Saad S, Delghandi MP, Busund LT, Bremnes RM. Donnem T, et al. Lung Cancer. 2009 Feb;63(2):277-83. doi: 10.1016/j.lungcan.2008.05.022. Epub 2008 Jul 2. Lung Cancer. 2009. PMID: 18599153

5

Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.

Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT. Al-Shibli KI, et al. Among authors: donnem t. Clin Cancer Res. 2008 Aug 15;14(16):5220-7. doi: 10.1158/1078-0432.CCR-08-0133. Clin Cancer Res. 2008. PMID: 18698040

6

Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.

Donnem T, Al-Saad S, Al-Shibli K, Andersen S, Busund LT, Bremnes RM. Donnem T, et al. J Thorac Oncol. 2008 Sep;3(9):963-70. doi: 10.1097/JTO.0b013e3181834f52. J Thorac Oncol. 2008. PMID: 18758297 Free article.

7

The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer.

Al-Saad S, Al-Shibli K, Donnem T, Persson M, Bremnes RM, Busund LT. Al-Saad S, et al. Among authors: donnem t. Br J Cancer. 2008 Nov 4;99(9):1476-83. doi: 10.1038/sj.bjc.6604713. Epub 2008 Oct 14. Br J Cancer. 2008. PMID: 18854838 Free PMC article.

8

Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapy.

Andersen S, Donnem T, Al-Saad S, Al-Shibli K, Busund LT, Bremnes RM. Andersen S, et al. Among authors: donnem t. J Thorac Oncol. 2009 Apr;4(4):463-71. doi: 10.1097/JTO.0b013e3181991d18. J Thorac Oncol. 2009. PMID: 19204576 Free article.

9

Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.

Donnem T, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM. Donnem T, et al. J Thorac Oncol. 2009 May;4(5):578-85. doi: 10.1097/JTO.0b013e31819f2e38. J Thorac Oncol. 2009. PMID: 19318994 Free article.

10

Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer.

Donnem T, Al-Saad S, Al-Shibli K, Busund LT, Bremnes RM. Donnem T, et al. Ann Oncol. 2010 Feb;21(2):223-231. doi: 10.1093/annonc/mdp296. Epub 2009 Jul 23. Ann Oncol. 2010. PMID: 19628565 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters